Ritanserin in the treatment of generaliz
✍
E. A. Pangalila-Ratu Langi; A. A. I. Jansen
📂
Article
📅
1988
🏛
John Wiley and Sons
🌐
English
⚖ 381 KB
👁 2 views
In a double-blind trial, 22 patients treated with 5 mg b.i.d. of the selective serotonin-S2 antagonist ritanserin for 4 weeks were compared with 26 patients treated with placebo for generalized anxiety disorder (DSM 111: 300.02). Symptoms were assessed using the Hamilton Anxiety Rating Scale (HARS)